February 10, 2026

Novel LIFR Variant Identified in Stuve-Wiedemann Syndrome

Case report highlights the role of early genetic confirmation in severe skeletal dysplasia

Conexiant

February 06, 2026

Biomarkers Expand Precision in CRC

Emerging biomarkers guide colorectal cancer diagnosis, stratification, and treatment selection

Conexiant

February 05, 2026

How AI Is Shaping Thyroid Disease Care

A new review finds AI is transforming thyroid disease care across imaging, pathology, and follow-up, but gaps in generalizability, transparency, and clinical integration persist.

Conexiant

February 04, 2026

FDA Expands HPV Primary Screening Options

Regulatory action broadens available approaches for cervical cancer screening in US clinical practice.

Conexiant

February 04, 2026

Plasma pTau217 Cutoffs for Clinical Use

Researchers assess how biological factors influence plasma biomarker interpretation for amyloid detection.

Conexiant

February 02, 2026

Atypical Testing in the Viral Era

Study questions routine testing for atypical bacterial co-infection in viral respiratory hospitalizations

Conexiant

January 30, 2026

Alzheimer Biomarkers Higher in Women

Researchers identify sex-specific differences in amyloid, tau, and brain structure during the seventh decade of life.

Conexiant

January 27, 2026

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Conexiant

January 20, 2026

APOE Utilization Tied to Most AD Cases

Apolipoprotein E ε3 and ε4 genotypes account for most Alzheimer's disease and nearly half of all-cause dementia.*

Conexiant